Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
AEVIS VICTORIA SA ( (CH:AEVS) ) has shared an update.
AEVIS VICTORIA SA reported a significant increase in sales and free cash flow in the first half of 2025, allowing for substantial debt reduction. The company’s strategic initiatives, including the integration of Spital Zofingen and CentroMedico, have strengthened its market position, leading to sustainable growth across its healthcare and hospitality sectors. The company aims to resume its dividend policy in 2026, reflecting its improved financial health and market positioning.
The most recent analyst rating on (CH:AEVS) stock is a Hold with a CHF13.50 price target. To see the full list of analyst forecasts on AEVIS VICTORIA SA stock, see the CH:AEVS Stock Forecast page.
More about AEVIS VICTORIA SA
AEVIS VICTORIA SA is a Swiss investment company focusing on healthcare, lifestyle, and infrastructure sectors. Its main holdings include Swiss Medical Network, a private hospital group, MRH Switzerland AG, a hotel chain, and Infracore SA, which specializes in hospital and healthcare infrastructure. The company is listed on the SIX Swiss Exchange.
Average Trading Volume: 6,046
Technical Sentiment Signal: Sell
Current Market Cap: CHF1.14B
Find detailed analytics on AEVS stock on TipRanks’ Stock Analysis page.